Supporting various operational activities of the CEPI secretariat - main funding envelope (360G-Wellcome-208476_B_17_Z)
CEPI is in start-up phase until the end of 2017. During this period, an Interim Secretariat provided by the Government of Norway is coordinating CEPI activity with close support from the Government of India, Wellcome Trust, the Bill & Melinda Gates Foundation, and the World Economic Forum. John-Arne Røttingen, from the Norwegian Institute of Public Health, was appointed Interim Chief Executive Officer of CEPI in June 2016. A permanent CEO will be appointed Q1 2017. The Interim Board, with representatives from founding partners, industry, governments and non-governmental organisations, is chaired by K. Vijay Raghavan, Secretary of the Department of Biotechnology of India, and with Peter Piot, Director of the London School of Hygiene and Tropical Medicine, as vice-chair.
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded | 80680175 |
| Applicant Surname | Hatchett IV |
| Approval Committee | Internal Decision Panel |
| Award Date | 2017-05-15T00:00:00+00:00 |
| Financial Year | 2016/17 |
| Grant Programme: Title | Discretionary Award - Vaccines |
| Internal ID | 208476/B/17/Z |
| Lead Applicant | Dr Richard Hatchett IV |
| Partnership Value | 80680175 |
| Planned Dates: End Date | 2023-03-31T00:00:00+00:00 |
| Planned Dates: Start Date | 2018-01-01T00:00:00+00:00 |
| Recipient Org: Country | Norway |
| Region | International |